Trial Details
COMPLETEDBasic Information
| Clinical ID | c4033 |
|---|---|
| Identifier | NCT01155362 |
| Trial Title | A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Human Placenta-Derived Cells PDA001 Intravenous Infusion|DRUG: Vehice Control |
Participant Information
| Sponsor | Celularity Incorporated |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2010-08 |
|---|---|
| Primary Completion Date | 2012-02 |
| Completion Date | 2014-04 |